Genetic selection for enhanced folding in vivo targets the cys14-cys38 disulfide bond in bovine pancreatic trypsin inhibitor

Antioxidants and Redox Signaling

Volumn 14, Issue 6, 2011, Pages 973-984

  Foit, Linda ^a   Mueller Schickert, Antje ^a   Mamathambika, Bharath S ^a   Gleiter, Stefan ^a   Klaska, Caitlyn L ^a   Ren, Guoping ^a   Bardwell, James C A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BETA LACTAMASE; PROTEINASE; TETRACYCLINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; COVALENT BOND; CYTOPLASM; DISULFIDE BOND; ESCHERICHIA COLI; GENETIC SELECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN STABILITY;

ANIMALS; APROTININ; BETA-LACTAMASES; CATTLE; DISULFIDES; ESCHERICHIA COLI; MODELS, BIOLOGICAL; PROTEIN FOLDING;

BOVINAE; ESCHERICHIA COLI;

EID: 79951938508     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3712     Document Type: Article

References (50)

1. Bulaj G and Goldenberg DP. Early events in the disulfide-coupled folding of BPTI. Protein Sci 8: 1825-1842, 1999.
2. Coplen LJ, Frieden RW, and Goldenberg DP. A genetic screen to identify variants of bovine pancreatic trypsin inhibitor with altered folding energetics. Proteins 7: 16-31, 1990. (Pubitemid 20102599)
3. Cornelis P. Expressing genes in different Escherichia coli compartments. Curr Opin Biotechnol 11: 450-454, 2000.
4. Creighton T. Disulphide-coupled protein folding pathways. Philos Trans R Soc Lond B Biol Sci 348: 5-10, 1995.
5. Creighton TE. Conformational restrictions on the pathway of folding and unfolding of the pancreatic trypsin inhibitor. J Mol Biol 113: 275-293, 1977. (Pubitemid 8150303)
6. Creighton TE. Protein folding pathways determined using disulphide bonds. Bioessays 14: 195-199, 1992.
7. Creighton TE and Goldenberg DP. Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J Mol Biol 179: 497-526, 1984. (Pubitemid 16223357)
8. Dadlez M and Kim PS. A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor. Nat Struct Biol 2: 674-679, 1995.
9. Dadlez M and Kim PS. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding. Biochemistry 35: 16153-16164, 1996. (Pubitemid 27044077)
10. Darby NJ, Morin PE, Talbo G, and Creighton TE. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates. J Mol Biol 249: 463-477, 1995.
11. Darby NJ, van Mierlo CP, and Creighton TE. The 5-55 single-disulphide intermediate in folding of bovine pancreatic trypsin inhibitor. FEBS Lett 279: 61-64, 1991.
12. Ferrer M, Barany G, and Woodward C. Partially folded, molten globule and molten coil states of bovine pancreatic trypsin inhibitor. Nat Struct Biol 2: 211-217, 1995.
13. Foit L, Morgan GJ, Kern MJ, Steimer LR, von Hacht AA, Titchmarsh J, Warriner SL, Radford SE, and Bardwell JC. Optimizing protein stability in vivo. Mol Cell 36: 861-871, 2009.
14. Fremaux I, Mazeres S, Brisson-Lougarre A, Arnaud M, Ladurantie C, and Fournier D. Improvement of Drosophila acetylcholinesterase stability by elimination of a free cysteine. BMC Biochem 3: 21, 2002.
15. Goldenberg DP. Kinetic analysis of the folding and unfolding of a mutant form of bovine pancreatic trypsin inhibitor lacking the cysteine-14 and - 38 thiols. Biochemistry 27: 2481-2489, 1988.
16. Goldenberg DP. Native and non-native intermediates in the BPTI folding pathway. Trends Biochem Sci 17: 257-261, 1992.
17. Goldenberg DP, Bekeart LS, Laheru DA, and Zhou JD. Probing the determinants of disulfide stability in native pancreatic trypsin inhibitor. Biochemistry 32: 2835-2844, 1993. (Pubitemid 23102807)
18. Goldenberg DP, Berger JM, Laheru DA, Wooden S, and Zhang JX. Genetic dissection of pancreatic trypsin inhibitor. Proc Natl Acad Sci USA 89: 5083-5087, 1992.
19. Hiniker A, Collet JF, and Bardwell JC. Copper stress causes an in vivo requirement for the Escherichia coli disulfide isomerase DsbC. J Biol Chem 280: 33785-33791, 2005. (Pubitemid 41443097)
20. Ignatova Z. Monitoring protein stability in vivo. Microb Cell Fact 4: 23, 2005.
21. Ishikawa M, Iijima H, Satake-Ishikawa R, Tsumura H, Iwamatsu A, Kadoya T, Shimada Y, Fukamachi H, Kobayashi K, Matsuki S, et al. The substitution of cysteine 17 of recombinant human G-CSF with alanine greatly enhanced its stability. Cell Struct Funct 17: 61-65, 1992.
22. Kibria FM and Lees WJ. Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide. J Am Chem Soc 130: 796-797, 2008.
23. Kirby AJ. Effective molarities for intramolecular reactions. Adv Phy Org Chem 17: 183-278, 1980.
24. Kowalski JM, Parekh RN, and Wittrup KD. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 37: 1264-1273, 1998. (Pubitemid 28135713)
25. Krebber C, Spada S, Desplancq D, Krebber A, Ge L, and Pluckthun A. Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions. J Mol Biol 268: 607-618, 1997. (Pubitemid 27208078)
26. Krokoszynska I, Dadlez M, and Otlewski J. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin. J Mol Biol 275: 503-513, 1998. (Pubitemid 28055069)
27. Leatherbarrow RJ and Fersht AR. Protein engineering. Protein Eng 1: 7-16, 1986.
28. Marks CB, Naderi H, Kosen PA, Kuntz ID, and Anderson S. Mutants of bovine pancreatic trypsin inhibitor lacking cysteines 14 and 38 can fold properly. Science 235: 1370-1373, 1987. (Pubitemid 17041655)
29. Martin A, Schmid FX, and Sieber V. Proside: a phage-based method for selecting thermostable proteins. Methods Mol Biol 230: 57-70, 2003.
30. McRee DE, Redford SM, Getzoff ED, Lepock JR, Hallewell RA, and Tainer JA. Changes in crystallographic structure and thermostability of a Cu, Zn superoxide dismutase mutant resulting from the removal of a buried cysteine. J Biol Chem 265: 14234-14241, 1990.
31. Nilsson B, Berman-Marks C, Kuntz ID, and Anderson S. Secretion incompetence of bovine pancreatic trypsin inhibitor expressed in Escherichia coli. J Biol Chem 266: 2970-2977, 1991. (Pubitemid 21909162)
32. Ostermeier M, De Sutter K, and Georgiou G. Eukaryotic protein disulfide isomerase complements Escherichia coli dsbA mutants and increases the yield of a heterologous secreted protein with disulfide bonds. J Biol Chem 271: 10616-10622, 1996. (Pubitemid 26145795)
33. Ostermeier M and Georgiou G. The folding of bovine pancreatic trypsin inhibitor in the Escherichia coli periplasm. J Biol Chem 269: 21072-21077, 1994. (Pubitemid 24266477)
34. Raines RT. Ribonuclease A. Chem Rev 98: 1045-1066, 1998.
35. Raso SW, Abel J, Barnes JM, Maloney KM, Pipes G, Treuheit MJ, King J, and Brems DN. Aggregation of granulocytecolony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci 14: 2246-2257, 2005. (Pubitemid 41252793)
36. Schwarz H, Hinz HJ, Mehlich A, Tschesche H, and Wenzel HR. Stability studies on derivatives of the bovine pancreatic trypsin inhibitor. Biochemistry 26: 3544-3551, 1987.
37. Segatori L, Paukstelis PJ, Gilbert HF, and Georgiou G. Engineered DsbC chimeras catalyze both protein oxidation and disulfide-bond isomerization in Escherichia coli: reconciling two competing pathways. Proc Natl Acad Sci USA 101: 10018-10023, 2004. (Pubitemid 38891187)
38. Sevier CS and Kaiser CA. Formation and transfer of disulphide bonds in living cells. Nat Rev Mol Cell Biol 3: 836-847, 2002. (Pubitemid 35285274)
39. Stassinopoulou CI, Wagner G, and Wuthrich K. Two-dimensional 1H NMR of two chemically modified analogs of the basic pancreatic trypsin inhibitor. Sequence-specific resonance assignments and sequence location of conformation changes relative to the native protein. Eur J Biochem 145: 423-430, 1984. (Pubitemid 15213316)
40. Swartz JR. Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol 12: 195-201, 2001. (Pubitemid 32247408)
41. van Mierlo CP, Darby NJ, Keeler J, Neuhaus D, and Creighton TE. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements. J Mol Biol 229: 1125-1146, 1993. (Pubitemid 23091824)
42. van Mierlo CP, Darby NJ, Neuhaus D, and Creighton TE. (14-38, 30-51) double-disulphide intermediate in folding of bovine pancreatic trypsin inhibitor: a two-dimensional 1H nuclear magnetic resonance study. J Mol Biol 222: 353-371, 1991. (Pubitemid 121004011)
43. van Mierlo CP, Darby NJ, Neuhaus D, and Creighton TE. Two-dimensional 1H nuclear magnetic resonance study of the (5-55) single-disulphide folding intermediate of bovine pancreatic trypsin inhibitor. J Mol Biol 222: 373-390, 1991. (Pubitemid 121004012)
44. Wagner G, Kalb AJ, and Wuthrich K. Conformational studies by 1H nuclear magnetic resonance of the basic pancreatic trypsin inhibitor after reduction of the disulfide bond between Cys-14 and Cys-38. Influence of charged protecting groups on the stability of the protein. Eur J Biochem 95: 249-253, 1979.
45. Weissman JS and Kim PS. A kinetic explanation for the rearrangement pathway of BPTI folding. Nat Struct Biol 2: 1123-1130, 1995.
46. Weissman JS and Kim PS. Reexamination of the folding of BPTI: predominance of native intermediates. Science 253: 1386-1393, 1991. s (Pubitemid 21917286)
47. Zakharova E, Horvath MP, and Goldenberg DP. Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor. J Mol Biol 382: 998-1013, 2008.
48. Zapun A and Creighton TE. Effects of DsbA on the disulfide folding of bovine pancreatic trypsin inhibitor and alphal-actalbumin. Biochemistry 33: 5202-5211, 1994. (Pubitemid 24150987)
49. Zhang JX and Goldenberg DP. Amino acid replacement that eliminates kinetic traps in the folding pathway of pancreatic trypsin inhibitor. Biochemistry 32: 14075-14081, 1993. (Pubitemid 24024530)
50. Zhang JX and Goldenberg DP. Mutational analysis of the BPTI folding pathway: I. Effects of aromatic - > leucine substitutions on the distribution of folding intermediates. Protein Sci 6: 1549-1562, 1997.